Medtech M&A Madness | Wall Street Beat
Federal circuit defends InSite Vision’s win over San Francisco university
InSite Vision (OTC:INSV) eked out a narrow win against the University of California in San Francisco in a patent battle over eye treatment.
Angeion narrows Q1 losses despite flat sales | Earnings Roundup
Angeion Corp. (NSDQ:ANGN) narrowed its 1st-quarter losses despite flat sales for the 3 months ended Jan. 31.
Although dragged down by a tough European climate, focusing on group purchasing organization and service revenues kept the company’s sales from sliding, the cardiorespiratory diagnostic systems maker said.
Philips takes another shot at Zoll over AED patents | Legal Roundup
Philips Healthcare (NYSE:PHG) plans to go another round with Zoll Medical Corp. (NSDQ:ZOLL) over automated external defibrillators, suing Zoll in Washington state over a new string of allegedly infringed patents.
Philips wants a jury to issue an injunction to keep Zoll from selling its AED Plus and AED Pro devices, as well as compensation for lost sales and legal fees.
Meelia says goodbye to Covidien | Personnel Moves
Former Covidien (NYSE:COV) president & CEO Richard Meelia decided not to stand for re-election as chairman of the med-tech maker’s board.
Meelia agreed to serve as a non-executive chairman of the Mansfield, Mass-based med-tech titan for a year after his retirement last July.
Texas doc nearly clear of over-stenting charges | Legal News
Dr. Samuel DeMaio
A Texas doctor accused of unnecessary stenting has slipped three of four trials against him with his license to practice in the Lone Star State intact.
Dr. Samuel DeMaio, accused last year of standard-of-care violations related to nine patients who allegedly received un-needed stents, angiograms and ICD implants, had pushed for a trial after mediation efforts with the Texas Medical Board collapsed.
Greatbatch tramples Wall Street estimates | Earnings Roundup
Greatbatch Inc. (NYSE:GB) shares are up today after the med-tech giant’s third-quarter earnings beat analysts’ expectations.
Clarance, N.Y.-based Greatbatch said third-quarter profits were $6.99 million, or 30 cents a share, on sales of $131 million for the three months ending Sept. 30, up 17.2 percent and 3.3 percent, respectively, compared with the same period last year.
Tengion CEO Nichtberger resigns | MassDevice.com Personnel Moves
Tengion Inc. (NSDQ:TNGN) chief scientific officer Timothy Bertram will handle CEO duties while the company searches for a new top executive following the June 30 resignation of Dr. Steven Nichtberger.
Hologic touts record revenues | Earnings Roundup
Hologic Inc. (NSDQ:HOLX) reported growth in sales and booming earnings its third quarter ended June 25, driven by increased revenues in its breast health sector, which includes its 3D mammography system.
Breast health revenues grew 8 percent to $205 million, compared to $189 million during the same period last year.
Bacterin Q1 sales bound 120 percent | Earnings roundup
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
MassDevice Network
@MassDevice
LinkedIn
YouTube